Patent classifications
C
CHEMISTRY; METALLURGY
Load children
C07
ORGANIC CHEMISTRY
Load children
C07C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
Load children
C07C255/01
having cyano groups bound to acyclic carbon atoms
Load children Filter patents View analytics View as hierarchy Open in page
C07C255/32
having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
Load children Filter patents View analytics View as hierarchy Open in page
C07C255/42
the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
Load children Filter patents View analytics View as hierarchy Open in page
C07C255/44
at least one of the singly-bound nitrogen atoms being acylated
Filter patents View analytics View as hierarchy Open in page

C07C255/44

FTO INHIBITORS
20260035341 · 2026-02-05 ·

Provided are a compound of Formula (I) as an FTO inhibitor with improved and selective FTO inhibition, a pharmaceutical composition comprising the same, and a method of inhibiting weight gain, promoting weight loss, reducing serum LDL, cholesterol, LDL-c, or triglycerides, or treating obesity or an obesity-related disease (esp. obesity-related diabetes, hyperglycemia, diabetic nephropathy, hyperlipemia, coronary heart disease, atherosclerosis, hypertension, cardiovascular or cerebrovascular disease) or Alzheimer's disease by inhibiting FTO by using the compound disclosed herein.

FTO INHIBITORS
20260035341 · 2026-02-05 ·

Provided are a compound of Formula (I) as an FTO inhibitor with improved and selective FTO inhibition, a pharmaceutical composition comprising the same, and a method of inhibiting weight gain, promoting weight loss, reducing serum LDL, cholesterol, LDL-c, or triglycerides, or treating obesity or an obesity-related disease (esp. obesity-related diabetes, hyperglycemia, diabetic nephropathy, hyperlipemia, coronary heart disease, atherosclerosis, hypertension, cardiovascular or cerebrovascular disease) or Alzheimer's disease by inhibiting FTO by using the compound disclosed herein.